Key result
Simvastatin nano-niosomes reduce cardiomyocyte apoptosis and autophagy compared with plain simvastatin in rat cardiac ischemia.
Answers are grounded in this paper and cite their sources.
Background. Cardiac ischemia is the major cause of morbidity and mortality which can be increased by Statins. This study aimed to increase the effectiveness of simvastatin in the form of niosomes. Methods. In this study, 25 male Wistar rats were divided into 5 groups: control, ischemia (induced by closed LAD), ischemia receiving nano-niosomes, ischemia receiving simvastatin, and ischemia receiving simvastatin-loaded nano-niosomes. One month after the drug injection, RNA was extracted from the heart tissue of the studied groups, cDNA was synthesized, and a real-time PCR test was performed using specific primers. SPSS 21.0 software was used for statistical analysis. Analysis of variance was used to investigate the effect of the interventions, and Tukey's post hoc test was used to investigate a significant difference (P<0.05) between the control groups and other groups as well as between intervention groups. Results. Apoptosis and autophagy increased significantly in the ischemia group compared to the control group (P<0.05). In the simvastatin-loaded nano-niosomes group, compared to the simvastatin group, apoptosis and autophagy showed a significant decrease (P<0.05), and also in both simvastatin-loaded nano-niosomes and simvastatin group, compared to the control group, apoptosis and autophagy showed a significant decrease. (P<0.05). Conclusion. Simvastatin is an effective drug in the recovery of cardiac ischemia, but the main problem in using simvastatin is its instability and degradability, and the use of its niosomes form solves this problem properly. Practical Implications. Simvastatin‑loaded nano‑niosomes is more effective in reducing heart ischemia damage compared to simvastatin.
No takes yet. Share an insight, caveat, or question.
Aboutaleb et al. (2023) studied Cardiac ischemia (induced by closed LAD in rats) (n=25). Simvastatin-loaded nano-niosomes vs. Simvastatin, nano-niosomes alone, untreated ischemia, and control was evaluated on Cardiomyocyte apoptosis and autophagy (measured via real-time PCR of heart tissue RNA) (p=<0.05). Simvastatin-loaded nano-niosomes decreased cardiomyocyte apoptosis and autophagy compared to plain simvastatin in rats with cardiac ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: